Page last updated: 2024-10-30

mecamylamine and Genetic Predisposition

mecamylamine has been researched along with Genetic Predisposition in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research Excerpts

ExcerptRelevanceReference
"Because nicotine dependence (ND) is highly comorbid with schizophrenia and other substance abuse, we examined the association of HINT1 with ND."1.37Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence. ( Aggen, SH; Chen, J; Chen, Q; Chen, X; Jackson, KJ; Kendler, KS, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dash, B1
Lukas, RJ1
Li, MD1
Jackson, KJ1
Chen, Q1
Chen, J1
Aggen, SH1
Kendler, KS1
Chen, X1

Other Studies

2 other studies available for mecamylamine and Genetic Predisposition

ArticleYear
A signal peptide missense mutation associated with nicotine dependence alters α2*-nicotinic acetylcholine receptor function.
    Neuropharmacology, 2014, Volume: 79

    Topics: Acetylcholine; Amino Acid Sequence; Animals; Genetic Predisposition to Disease; Humans; Mecamylamine

2014
Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence.
    The pharmacogenomics journal, 2011, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Aged; Animals; Autopsy; Brain; Gene Frequency; Genetic Predisposition to Disease;

2011